BioSpace News Archive

Press Releases

Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024

October 10, 2024
·
5 min read
Press Releases

Immatics Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial

October 10, 2024
·
14 min read
Press Releases

Zymeworks to Report Third Quarter 2024 Financial Results and Host Conference Call on October 31, 2024

October 10, 2024
·
2 min read
Press Releases

Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial

October 10, 2024
·
19 min read
Press Releases

Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders

October 10, 2024
·
10 min read
Press Releases

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

October 10, 2024
·
1 min read
Press Releases

Foghorn Therapeutics Announces First Patient Dosed with First-in-Class Oral SMARCA2 Selective Inhibitor FHD-909 in a Phase 1 Trial for SMARCA4 Mutated Solid Tumors

October 10, 2024
·
4 min read
Press Releases

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

October 10, 2024
·
6 min read
Press Releases

TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology

October 10, 2024
·
5 min read
Press Releases

BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting

October 10, 2024
·
5 min read